A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:
NCT: NCT06676072 · COMPLETED
Brief Summary
The objective of this clinical study is to demonstrate that ablation with the TactiFlex SE Ablation catheter, in conjunction with a compatible pulsed field ablation (PFA) and/or radio frequency (RF) generator, is safe and effective for the treatment of symptomatic, recurrent, drug refractory paroxysmal atrial fibrillation (PAF).
Frequently Asked Questions
What is A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:?
A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: is a clinical trial registered under NCT06676072. Current status: COMPLETED.
What is the status of NCT06676072?
The current status of NCT06676072 (A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:) is: COMPLETED.
When did A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: start?
A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: started on 2024-11-22.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.